Results 211 to 220 of about 7,313,278 (356)
AZD9291 has shown promise in targeted cancer therapy but is limited by resistance. In this study, we employed metabolic labeling and LC–MS/MS to profile time‐resolved nascent protein perturbations, allowing dynamic tracking of drug‐responsive proteins. We demonstrated that increased NNMT expression is associated with drug resistance, highlighting NNMT ...
Zhanwu Hou+5 more
wiley +1 more source
Population genetic approaches to estimating the size of the HIV reservoir
J. Hattori+4 more
doaj
Human Gut Bacteriophageome: Insights Into Drug Resistance Mechanisms in Tuberculosis. [PDF]
Jafari E+4 more
europepmc +1 more source
STUDIES ON TRANSFERABLE DRUG RESISTANCE IN BACTERIA [PDF]
Masanosuke Yoshikawa, Tomoichiro Akiba
openalex +1 more source
Understanding and measuring mechanical signals in the tumor stroma
This review discusses cancer‐associated fibroblast subtypes and their functions, particularly in relation to extracellular matrix production, as well as the development of 3D models to study tumor stroma mechanics in vitro. Several quantitative techniques to measure tissue mechanical properties are also described, to emphasize the diagnostic and ...
Fàtima de la Jara Ortiz+3 more
wiley +1 more source
The role and mechanism of fatty acid oxidation in cancer drug resistance. [PDF]
Lei Y+7 more
europepmc +1 more source
The tumor microenvironment is a dynamic, multifaceted complex system of interdependent cellular, biochemical, and biophysical components. Three‐dimensional in vitro models of the tumor microenvironment enable a better understanding of these interactions and their impact on cancer progression and therapeutic resistance.
Salma T. Rafik+3 more
wiley +1 more source
Objective: Carbapenem-resistant Pseudomonas aeruginosa (CRPA) is an important antimicrobial-resistant bacterial pathogen. We observed an increase in the detection rate of CRPA isolates at a tertiary children’s hospital in Japan.
Akihiko Shimizu+8 more
doaj
Intratumoral heterogeneity and drug resistance in cancer. [PDF]
Fu YC, Liang SB, Luo M, Wang XP.
europepmc +1 more source